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Summary 
The selectin class of adhesion molecules plays a critical role in facilitating leukocyte adhesion to 
and subsequent transmigration of endothelium. On this basis, selectins have been suggested to 
promote tumor cell attachment to endothelium, thereby facilitating metastasis  of certain types 
of tumors, although direct evidence for such a role is lacking. To explore this hypothesis, two 
sets  of transgenic  mice were  developed: TgnES,  which  constitutively expresses cell surface 
E-selectin in all tissues,  under the control of the [3-actin  promoter; and TgnEsol, which ex- 
presses  truncated, soluble E-selectin in the liver, under the control of the o~1 antitrypsin pro- 
moter.  B16F10  melanoma  cells  were  stably  transfected with  0t(1,3/1,4)  fucosyltransferase- 
specific cDNA  (B16F10ft), allowing them to express E-selectin ligands  or with hygromycin 
resistance  selection  vector  only  (B16F10hygro).  Normal  mice  injected  with  B16F10ft  and 
B16FlOhygro  and transgenic mice injected with B16F10hygro  developed lung tumors  exclu- 
sively. In contrast, TgnES mice injected with B16F10ft cells developed massive infiltrating liver 
tumors. B16F10ft cells injected into TgnEsol mice also formed liver tumors, but these grew 
more slowly, with a well-delineated, noninfiltrating distinct histologic pattern. These observa- 
tions provide direct evidence that expression of E-selectin can redirect metastasis  of tumor cells 
expressing appropriate ligands  in vivo. 
T 
umor  metastasis  is  a  multistep  process requiring  de- 
tachment of malignant  cells  from the primary tumor 
mass, penetration of blood and/or lymph vessels, evasion of 
immune surveillance, attachment to endothelium of distant 
organs, penetration of the secondary host tissue,  and forma- 
tion of new tumor colonies. The ability of tumor cells to 
selectively adhere to endothelium of certain organs may be 
responsible in part for preferential metastatic patterns asso- 
ciated with different tumor types. Interaction between tu- 
mor cells and host tissue endothelium is thought to be me- 
diated by adhesion receptor-ligand pairs,  some  of which 
are involved in physiologic leukocyte-endothelial interac- 
tions (1). Tumor cells express various combinations of cell 
surface molecules that may serve as ligands for endothelial 
cell  surface  receptors  (2-7),  which  are  typically induced 
upon  stimulation by mediators  of inflammation  (2-4).  A 
local inflammatory response may therefore facilitate circu- 
lating tumor cell adhesion and arrest. 
Two members of the selectin family of adhesion mole- 
cules, E- and P-selectin, are transiently expressed on endo- 
thelial cells after stimulation by IL-1 and TNF-ot. Both re- 
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ceptors recognize sialylated fucosylated lactosaminoglycans 
on  the  surface of various leukocyte subsets  and promote 
leukocyte rolling on the cytokine-activated endothelial sur- 
face, facilitating subsequent leukocyte arrest and extravasa- 
tion to sites of injury (4). E-selectin has been proposed to 
facilitate attachment of tumor cells to endothelium in simi- 
lar fashion (4). This suggestion is based on observations that 
several types of malignancy express elevated levels of a fu- 
cosyltransferase  required  for  the  synthesis  of E-selectin- 
binding  oligosaccharides  and  that  adhesiveness  of several 
colon carcinoma cell lines to E-selectin-expressing endo- 
thelial cells in vitro correlates with their metastatic procliv- 
ity in vivo (3, 7, 8). However, direct evidence of involve- 
ment of E-selectin in tumor metastasis  in vivo is lacking. 
To address  the possible role of E-selectin expression in 
tumor metastasis  in vivo, B16F10 melanoma cells,  which 
typically form tumors primarily in  the lung and lack  cell 
surface  expression of E-selectin ligands,  were  transfected 
with  ~x(1,3/1,4)  fucosyltransferase cDNA  and  tested  for 
their pattern of hematogenous dissemination in transgenic 
mice constitutively expressing cell surface or soluble E-selec- 
tin.  Our results indicate that expression of E-selectin can 
redirect metastasis of  tumor cells expressing appropriate ligands 
in vivo. 
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Development of Transgene Constructs.  To make the cell surface 
E-selectin transgene,  a  BamHI  fragment  of mouse  E-selectin 
cDNA (nucleotides 83-2,108, EMBL accession number M80778) 
was inserted into the Klenow polymerase-filled EcoiLI site of the 
pCAGGS expression  vector (9). For microinjection, the SnaBI/ 
BamHI fragment was isolated (see Fig. 1). 
To make the soluble  E-selectin transgene,  the oL1  antitrypsin 
promoter, isolated from human genomic DNA (EMBL accession 
number D38257)  by PCR using synthetic oligonucleotide prim- 
ers, was ligated to rabbit ~3-globin splice (nucleotides  902-1,542) 
and  polyA  signal  (nucleotides  1543-2180)  sequences,  derived 
from the  pKCR vector  (10), and the  ligation product was  in- 
serted  into  a  BssHII/XhoI-cut Bluescript  II  plasmid.  Mouse 
E-selectin cDNA  was  subjected  to  EcoiLI  digestion,  and  the 
EcoRI-cut fragment,  containing  sequences encoding a portion of 
the extracellular domain (nucleotides 83-1506) were inserted into 
the EcoiLI site between the [3-globin intron and polyA sequences 
in the  pBluescriptlI vector containing the  AAT promoter and 
~-globin intron/polyA segments  (the  5'  EcoiLl  site  was  de- 
stroyed  by blunting). To generate a soluble  form of E-selectin 
composed of the  entire extracellular  domain, a stop  codon was 
inserted by  PCIL  into  the  E-selectin cDNA  immediately up- 
stream of sequences encoding the transmembrane domain, using a 
reverse  primer designed to  contain an EcoiLI  site at nucleotide 
position 1822 as follows: 5' TTT GAA TTC AGG CCT GGC 
TGA CTG GGG CTT CAC A 3'. This and a forward primer 
spanning the Ecog.I site at nucelotide 1,506 were used to PCIL 
amplify sequences  encoding the membrane-proximal portion of 
the extracellular domain. The amplified product was subjected to 
EcoiLI digestion and ligated into the EcoiLI-cut AAT/E-selectin 
vector (see Fig. 1 B). For microinjection, the BssHII/XhoI frag- 
ment was isolated  (see Fig.  1).  Detection of each transgene was 
achieved by PCtL, using synthetic oligonucleotide primers corre- 
sponding to  appropriate  segments  of promoter  and  E-selectin 
coding sequences,  and by Southern blot using full-length mouse 
E-selectin cDNA as a probe. 
Mice.  C57B1/6xDBA2  F1  and C57B1/6  mice of either sex 
were  purchased  from IFFA Credo  (L'Abresles,  France).  Trans- 
genic founder mice were then backcrossed with C57/BL/6 mice 
in the animal facilities of the Centre Medical Universitaire, Uni- 
versity of Geneva. To generate  transgenic  mice, the DNA frag- 
ments shown in Fig. 1 were excised with the restriction endonu- 
cleases indicated above and purified by agarose gel electrophoresis 
and passage through NACS PREPAC (GIBCO BILL, Gaithers- 
burg, MD). The recovered DNA was resuspended in 1 mM Tris- 
HC1, pH 7.5,  0.1  mM EDTA, at 5 ng/p2 and used for micro- 
injection.  Founder mice  were  explored  for  the  presence  and 
number of copies of the transgene by Southern blot analysis, and 
their transgenic progeny were detected by PCIL analysis. 
RNA Blot Analysis.  Total  RNA  from  murine  tissues ob- 
tained at autopsy was prepared using the guanidinium thiocyan- 
ate/cesium chloride method.  20  Ixg of each  total RNA sample 
were loaded onto gels, subjected to electrophoresis,  transfered to 
nylon filters,  and hybridized to  a  full-length mouse E-selectin 
cDNA probe (11). 
Detection of Soluble E-Selectin  in Sera.  Detection  of  soluble 
E-selectin in sera was performed using an immunodot blot sys- 
tem.  100  I*1 of PBS-diluted normal or transgenic mouse serum 
was blotted onto a nitrocellulose membrane using a 96-well filtra- 
tion manifold (Hybri-dot; GIBCO BRL).  The membrane was 
washed with PBS and TBS-T (0.1% Tween-20 in 20 mM Tris- 
HC1, pH 7.5,  150 mM NaC1) and incubated with 1% blocking 
reagent (Boehringer Mannheim Corp., Indianapolis, IN) in TBS-T 
for 1 h at room temperature to block nonspecific antibody bind- 
ing. A rat anti-mouse E-selectin mAb 21KC10 (12) followed by 
an AP-conjugated mouse anti-rat Ig K chain mAb were used to 
detect soluble E-selectin. Serum concentrations were determined 
after  the  establishment  of a  standard  curve  by  adding known 
amounts of E-selectin-Ig-Fc fusion protein (12) to normal mouse 
serum, 
Cell Lines, Transfectants, and Injection of Cells into Mice.  The mu- 
rine B16F10 melanoma and the human myeloid leukemia HL60 
were  obtained  from  the  American  Type  Culture  Collection 
(Rockville, MD). Cells were transfected with "rrH3M vector con- 
taining the hygromycin resistance gene only or with ";rH3M vec- 
tor containing a(1,3/1,4)fucosyltransferase  cDNA (13). Transfec- 
rants were generated by electroporation (Gene Pulser; Bio-iLad 
Laboratories,  Richmond, CA)  at  250 V  and 960  IxF in 4-mm 
electroporation cuvettes.  Clones were  selected  for  hygromycin 
resistance in DMEM,  10% FCS,  and 500  p~g/ml hygromycin B 
(Boehringer Mannheim Corp.) and tested for sialyl Lewis  x (SLe  ￿ 
and sialyl Lewis  a (SLe  a) expression by flow cytometry. 
For in vivo experiments,  cells were detached from plates with 
EDTA, washed  with PBS, and resuspended  in saline. 0.2  ￿  106 
cells in a total vol of 250 Ixl were injected through the tail vein. 
All animals were killed on day 22 after injection and subjected to 
autopsy. All organs were examined macroscopically  for evidence 
of tumor growth.  Portions of liver,  lung, and brain tissue from 
each animal as well as any tissue containing visible tumor growth 
were fixed in formaldehyde or frozen in liquid nitrogen for light 
microscopy and immunofluorescence  studies, respectively. 
Antibodies and lmmunofluorescence.  Cells  were  detached from 
plates with EDTA, washed,  resuspended  in PBS, and incubated 
with mAbs for 45  rain at  4~  followed by fluorescein-labeled 
goat  anti-mouse afffinity-purified antibody (Cappel  Laboratories, 
Malvern, PA) for 30 rain at 4~  Binding ofmAb to cells was an- 
alyzed by flow cytometry. Anti-SLe  a mAb CSLEA-1  and anti- 
SLe  x mAb CSLEX  (14) were  obtained from the  Fifth  Human 
Leukocyte  Typing Workshop.  Control  isotype-matched  anti- 
bodies were from PharMingen (San Diego, CA). For tissue stain- 
ing, 5-p~m frozen tissue sections were mounted onto slides, fixed 
in cold acetone for 5 rain, air dried, and incubated with 10 p~g/ml 
of 10E9.6  rat  anti-murine E-selectin mAb (12) or control iso- 
type-matched antibody (PharMingen) for 45 rain at room temper- 
ature. The slides were washed  in PBS,  incubated with fluores- 
cein-labeled goat  anti-rat IgG affinity-purified antibody (Cappel 
Laboratories)  for  30  rain  at  room  temperature,  washed,  and 
examined  under  an  epifluorescence  microscope  (Nikon  Inc., 
Melville, NY). 
Results  and Discussion 
Development  of E-Selectin-Transgenic  (TgnES) Mice.  TgnES 
mice were transgenic lines in which the transgene consisted 
of full-length routine E-selectin cDNA placed under the 
control of the chicken [3-actin promoter (Fig. 1). Northern 
blot  analysis  of RNA  from  various  organs  of  F1  mice 
showed expression of the expected 2.6-kb transcript in aU 
tissues tested, including liver, kidney, brain, heart,  skeletal 
muscle, spleen and intestine (Fig. 1). Interestingly, the liver 
displayed the weakest E-selectin expression among the tis- 
582  E-Selectin Expression and Tumor Metastasis Figure 1.  Development ofE-selectin transgenes and expression of  E-selectin in transgenic mice. (A) Schematic representation of  the cell surface E-selec- 
tin transgene contruct. (B) Schematic representation of  the soluble E-selectin construct. (C) P,  NA blot analysis of cell surface E-selectin transgene expres- 
sion. 20 Wg of total P,  NA was loaded per lane, subjected to electrophoresis, transferred to nylon filters, and hybridized to a 32p-radiolabeled E-selectin 
cDNA probe (top). Comparative loading of  RNA samples onto the gel is shown in the lower panel. The origin of  RNA samples is denoted by letters: L, 
liver; K, kidney; B, brain; S, spleen; I, intestine; M, muscle; H, heart. 
sues  examined.  No  E-selectin  expression  was  detected  in 
tissues from normal mice (data not shown). 
TgnEsol mice were transgenic  lines in which the trans- 
gene consisted of a cDNA sequence encoding only the ex- 
tracellular  domain  of E-selectin,  placed  under  the  control 
of the Ix1 antitrypsin promoter, which is hepatic tissue spe- 
cific (Fig.  1). Analysis ofF1 mice using a dot blot assay re- 
vealed expression of soluble E-selectin in the serum in the 
range of 5-50 Fxg/ml. All mice used in this work belonged 
to  a  single  transgenic  line  of,  respectively,  TgnES  and 
TgnEsol transgenic mice raised on a C57B1/6 background. 
Development  of  B16F10  Melanoma  o~(1,3  /1, 4)  Fucosyl- 
transferase Transfectants.  B16F10 melanoma cells have been 
extensively studied  in  metastasis  assays  and have  been  ob- 
served  to  form  predominantly  lung  tumors  after  intrave- 
nous injection through the tail vein (15,  16). In preliminary 
experiments, injection of  B16F10 cells into normal, TgnES, 
or TgnEsol mice resulted in a comparable pattern of exclu- 
sively lung  metastasis  (data  not  shown).  Because  B16F10 
cells  do  not  express  E-selectin  ligands  (data  not  shown), 
B16F10ft variant cells  were developed that stably express a 
cDNA encoding an r  fucosyltransferase that catalyzes 
transglycosylation  reactions,  which  yield  both  Fuco~(1,3)- 
and  Fucc~(1,4)-glycosidic bonds  (13)  and  direct expression 
of E-selectin  ligands,  including  the  tetrasaccharides  SLe  a 
and  SLe  x  (17).  B16F10ft  cells  were  found  to  react  with 
CSLEA-1  mAb,  specific for SLe  a,  but not with  CSLEX-1 
m_Ab, specific for SLe  x (Fig. 2). Both antibodies stained HL60 
cells,  which express both tetrasaccharides  (data not shown). 
Recent studies  have shown that some melanoma cell lines 
that express  SLe  a but not SLe  ~, bind E- but not P-selectin 
(18). Expression ofSLe  a but not SLe  x has been suggested to 
correlate with melanoma metastatic proclivity (19). 
TgnES and TgnEsot Mice,  in  Contrast to Normal Mice,  De- 
velop Liver Metastasis,  but of a Different Macroscopic and Histo- 
logic Pattern.  Wild-type TgnES and TgnEsol mice (Table 
1)  were  injected  with  2  X  105  B16F10ft  or B16F10hygro 
cells  (transfected  with  the  hygromycin resistance  selection 
vector only) through the  tail vein and killed 22 days later. 
Wild-type C57B1/6 mice injected with B16F10ft as well as 
B16FlOhygro displayed multiple tumor nodules in the lungs 
but no detectable tumor growth in the liver or in other or- 
gans  (Table  1  and  Fig.  3).  Similarly,  lungs  were  the  only 
site of tumor growth in TgnES and TgnEsol mice injected 
with B16FlOhygro cells.  In contrast,  all  of the TgnES mice 
injected with B16F10ft cells  developed large hepatic tumor 
masses  with  diffuse  infiltration  of melanoma  cells  in  the 
liver parenchyma  (Fig.  3).  Small  tumor nodules were  also 
present  in  the  lung,  and  in  one  case  tumor infiltration  of 
mesenteric  lymph  nodes  and  the  pancreas  was  observed 
(Table  1). 
TgnEsol mice injected with B16F10ft cells also displayed 
hepatic tumors. However, contrary to the tumors observed 
in  TgnES  animals,  hepatic  tumors  in  TgnEsol  mice  pre- 
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Figure 2.  Expression  ofSLe  ~  and SLe  x in B16FlOhygro 
and Bl6F10ft cells. The ceils and antibodies used are 
indicated. An unrelated, isotype-matched  antibody was 
used as a control. Staining  was performed  with CSLEA-1 
and CSLEX mAbs. 
sented  as  several distinct,  round  1-2-mm nodules  (Fig.  4 
C). These animals also displayed tumor nodules in the lung 
and, in one case,  in the mesenteric lymph nodes (Table 1). 
At the completion of the study, only 33% of the TgnES an- 
imals  injected  with  B16F10ft  cells  were  ahve  compared 
with 100% of both TgnEsol and wild-type mice, whether 
they  were  injected  with  B16F10ft  or  B16F10hygro cells. 
The difference in survival probably reflects the more rapid 
growth of liver metastases in TgnES mice. 
Histologic examination showed a  striking morphologic 
Table  1.  Experimental  Groups and Tumor Distribution 
Metastasis 
Injected 
Mice  transfectant  Localization  Incidence 
Wild-typeC57B1/6  B16FlOhygro Lung  8/8 
Wild-type C57B1/6  B16F10ft  Lung  6/6 
TgnES  B16F10hygro  Lung  3/3 
TgnES  B16F10ft  Lung  6/6 
Liver  6/6 
Mesenteric LN  1/6 
TgnEsol  B16FlOhygro  Lung  4/4 
TgnEsol  B16F10ft  Lung  6/6 
Liver  5/6 
Mesenteric LN  1/6 
difference between Bt6F10ft liver tumors in the two trans- 
genic  lines.  In  TgnES  mice,  tumor  growth  appeared  to 
proceed by infiltration  of liver sinusoids  (Fig.  3).  In con- 
trast, in TgnEsol animals, tumors displayed spherical, well- 
circumscribed growth without infiltrating but rather com- 
pressing  the  hver  parenchyma  (Fig.  3).  These  distinct 
patterns of growth corresponded to the  different distribu- 
tion  of E-selectin expression in the liver between  TgnES 
and TgnEsol mice (Fig. 4).  tmmunohistochemical analysis 
revealed that E-selectin was predominantly localized on the 
endothelium of hver sinusoids  and venules in TgnES ani- 
mals (Fig.  4);  expression on the hepatocyte membrane was 
more difficult to  detect.  In TgnEsol mice, E-selectin was 
detected within hepatocytes, as expected from the presence 
of the o~1 antitrypsin promoter in the transgene (Fig.  3). 
Taken  together,  our  observations  demonstrate  the  po- 
tential importance of carbohydrate hgand-E-selectin inter- 
action in tumor metastasis in vivo. Although  it is obvious 
that interactions  between locally expressed E-selectin and 
melanoma cells bearing E-selectin ligands are directing the 
observed tumor growth pattern, differences in the gross and 
histologic  appearance  of hver  metastases,  which  depend 
upon  the  site  of E-selectin  expression,  indicate  different 
mechanisms  of interaction  between  tumor  cells  and  host 
tissue in the two transgenic lines. 
It may be asked why the liver appears to be the principal 
site of tumor colonization in TgnES mice; these mice ex- 
press the transgene in most organs, with an especially high 
level of expression in the heart and skeletal muscle (which 
is likely to be related to the use of the actin promoter) and 
584  E-Selectin Expression and Tumor Metastasis Figure 3.  Histology (hematoxylin and eosin) of  liver metastases from transgenic mice injected with B16F10ft. (a) Normal hver histology from a control 
C57B/6 mouse.  ￿  (b) Liver metastasis in a TgnES mouse. Arrows indicate tumor margins; arrowheads denote a satellite tumor infiltrating liver paren- 
chyma.  ￿  (c) Liver metastasis in a TgnEsol mouse.  Arrows indicate a well-defined tumor margin showing absence of sinusoid infiltration. ￿  (d) 
Higher magnification of tumor metastasis in TgnES mouse reveals diffuse tumor infiltration of the hver sinusoids (at:rows).  ￿  20. 
a lower level of expression in the liver. Interaction between 
endothehal  cells  bearing E-selectin  and  circulating tumor 
cells is most likely a  determining factor  in the localization 
of  early  metastases.  Immunohistochemistry  showed  that 
E-selectin expression was  high  on  endothelial cells  of the 
liver, but it was also elevated on endothelial cells of a frac- 
tion of vessels in cardiac and skeletal muscle, lung, and kid- 
ney (data not shown). Because the liver has a larger vascular 
network than muscle and most other organs, it provides tu- 
mor cells with more potential attachment sites and the pos- 
sibility to establish new colonies. In addition, the relatively 
low  shear  forces  in the  sinusoids and venules of the  liver 
may provide  a  contributing factor,  since expression of the 
E-selectin  transgene  was  prevalent  in  medium  and  large 
vessels of other organs. Thus, the rapid appearance of liver 
metastases in TgnES mice may be explained in part by or- 
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Figure  4.  Expression  of E-selectin  in transgenic 
mice. Immunofluorescence  staining for E-selectin in 
(A) TgnEsol mouse hver; (/3) TgnES mouse liver; (C) 
normal C57B1/6 mouse hver. E-selectin expression is 
predominantly localized along the sinusoids and veins 
in B and within the cytoplasm of the hepatocytes in 
A.  Indirect  immunofluorescence  was performed  by 
using rat anti-mouse E-selectin mAb clone  10E 9.6 
(10  p~g/ml) and a secondary fluorescein-conjugated 
afllnity-purified goat anti-rat antibody. gan-specific vascular anatomy  and  hemodynamics.  How- 
ever,  differences in  adhesiveness  of tumor  cells to  organ- 
specific microvasculature may also play a role. It is possible 
that, similar to leukocytes, tumor cell arrest and endothelial 
transmigration  require  several  sequential  interactions  be- 
tween tumor-associated receptors and endothelial cell ligands. 
E-selectin may thus provide an essential accessory adhesion 
component  that  may facilitate interactions between  other 
receptor-ligand pairs. Once the tumor cells are arrested in a 
given  tissue,  the  pattern  of metastatic  growth  is likely to 
become  more  dependent  on  interaction between  the  tu- 
mor and host tissue cells. Hepatocytes probably bore weak 
amounts of E-selectin in their membranes, which, together 
with  preferential tumor  cell adhesion  to  sinusoidal endo- 
thelium, may explain the infdtrating aspect of the liver tu- 
mor masses in TgnES  mice, as well as their rapid growth, 
leading  to  early  death  in  comparison  with  TgnEsol  and 
nontransgenic mice. 
It  was  expected  that  the  circulating soluble  E-selectin 
detected in TgnEsol mice would lead to a pattern of me- 
tastasis in which the E-selectin ligands borne by B16F10ft 
cells would play no role, i.e., comparable to that of B16F- 
l Ohygro  cells.  The  well-delimited,  noninfdtrating  tumor 
masses found in the liver may have resulted from the fact 
that, despite the presence of circulating soluble E-selectin, a 
gradient of the  transgene product released by the  hepato- 
cytes was likely to occur, with the highest existing concen- 
tration  at  the  level  of the  hepatic  sinusoids.  It  has  been 
suggested  that  soluble E-selectin may  act  as  a  neutrophil 
chemoattractant (20), and the same possibility may apply to 
the situation of E-selectin ligand-bearing cells in the pres- 
ence  of any  gradient  of soluble E-selectin concentration. 
The lack of direct interaction between tumor cells and hepa- 
tocytes, as well as the lack of membrane-bound cell surface 
E-selectin on  sinusoid  endothelium,  would  be  consistent 
with the noninftltrating nature of the liver metastasis. 
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